Please login to the form below

Not currently logged in
Email:
Password:

medicines access

This page shows the latest medicines access news and features for those working in and with pharma, biotech and healthcare.

Who's calling the shots in European healthcare?

Who's calling the shots in European healthcare?

Natsis is policy manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), a Brussels-based organisation made up of public health NGOs, patient groups, health professionals ... What I care about is how people

Latest news

More from news
Approximately 4 fully matching, plus 422 partially matching documents found.

Latest Intelligence

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Diarmaid McDonald is lead organiser of Just Treatment, a UK-based patient activist group which is challenging the government to take whatever steps necessary to ensure access to new medicines at ... Instead, they identified a legal loophole which allows

  • The UK’s new medicines pricing deal – opportunities and risks for pharma The UK’s new medicines pricing deal – opportunities and risks for pharma

    NHSE has sought a far stronger role when it comes to medicines pricing and access since it formally began its work in 2013. ... Getting medicines to patients. Like its predecessor, the 2019 VPAS directly addresses medicines access to patients, with the

  • The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt

    The deal is done. After undoubtedly tense negotiations, the heads of terms for the new Voluntary Scheme for Branded Medicines Pricing and Access have just been published, and although some among ... By Leslie Galloway, chairman, Ethical Medicines

  • The Orkambi row explained The Orkambi row explained

    Is the UK an extreme outlier in terms of market access for Orkambi? ... December 2018: Scottish Government agrees a deal with Vertex pending submission of Orkambi and Symkevi to Scottish Medicines Consortium (SMC), with interim access possible through

  • #OrkambiNow? #OrkambiNow?

    Photo credit: Cystic Fibrosis Trust. The long-running row over access to Vertex’s cystic fibrosis drug Orkambi has been one of the worst episodes for access to new medicines in ... per patient per year price – comparable to the cost of older and less

More from intelligence
Approximately 0 fully matching, plus 85 partially matching documents found.

Latest appointments

  • Pfizer’s Alan Maine moves to Edelman Pfizer’s Alan Maine moves to Edelman

    Maine, who previously served as head of policy and public affairs at Pfizer UK, was responsible for government affairs and market access policy development activity, covering both corporate and therapy area ... During his time at Pfizer, Maine also

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    May’s new role will see her lead the biopharma’s commercial team in bringing Sobi’s medicines to the country. ... She will also collaborate with the operations and patient access team to ensure the medicines are accessible to as many appropriate

  • Inceptua Medicines Access appoints senior new-hires Inceptua Medicines Access appoints senior new-hires

    Multipharma’s new speciality business unit, Inceptua has appointed Ruth Rostron as its new senior project manager, a role that will see her focus on design and implementation of medicines access

  • Sandoz UK promotes Tim de Gavre to country head Sandoz UK promotes Tim de Gavre to country head

    As a company, Sandoz has an exciting portfolio of medicines and future product pipeline. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... He also brings experience form Boehringer Ingelheim, where he

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • New opportunities in emerging markets

    This growth is set to continue. In parallel, we are seeing an increased focus among emerging market governments on public healthcare reform: expanding their populations’ access to medicines by establishing universal ... Greater purchasing power and

  • Uniphar Group plc appoints Graham McIntosh as Managing Director Commercial & Clinical (Pharma)

    McIntosh believes this to be an exciting time for the industry, embracing the vision to improve patient access to pharmaceutical medicines and treatments by developing connectivity between manufacturers and healthcare stakeholders. ... service which adds

  • Precision medicine from concept to clinic

    We have spoken to these stakeholders to chart their journeys and the role they play in ensuring patients can access precision medicines. ... Here, we reveal key insights to help you meet the needs of seven core stakeholders involved in launching and

  • Training the next generation of biotech leaders

    The goal is to try and accelerate access to these medicines by reducing the time taken to learn how to manufacture them. ... It would be nice to think that in the next ten to fifteen years, we’ll see a pipeline of new medicines emerging off the back of

  • Unique forum will unite NHS and industry to drive innovation

    HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare. ... and med tech sectors to work more closely with the NHS, to maximise value for money while

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics